4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-23-010954
Chief Legal Officer sold 8,275 shares at $3.00 ($24,825)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wilson Mark Andrew Chief Legal Officer | 2023-02-16 | Sale | −8,275 | $3.00 | $24,825 | 265,223 | D |
| Open-market sales · 8,275 sh · avg $3.00 · $24,825 | |||||||
Loading xslF345X03/doc4.xml…